Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO(TM) and Sonalleve(TM) with Al Faisaliah Medical Systems in Saudi Arabia
VVT Med Signs $3.7 Million Distribution Agreement in India, Achieves European Sales Milestone and Announces Proposed Debt Settlement
CardioComm Receives TSX Venture Exchange Approval for Announced Loan Facility
LevelJump Announces 2025 Third Quarter Results
Theralase Technologies loses $3.43-million in Q3
DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital
Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO(TM) in Canada from Knight
Lir Life Sciences Corp. Formerly Blackbird Critical Metals Corp. Announces Closing of Acquisition of Lir Life Sciences Inc.
ASEP licenses anti-biofilm peptide tech to Bondent
Arch Biopartners Arranges Non-Brokered Private Placement
Theralase(R) Releases 3Q2025 Financial Statements
Briacell presents Bria-OTS+ preclinical results at SITC
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+(TM) at SITC 2025
Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Quantum Biopharma Reports Strong Third Quarter Results Maintaining 'No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio